President Trump will announce findings on autism from the Oval Office on Monday. The announcement is expected to link autism development to Tylenol use during pregnancy and low folate levels, suggesting folinic acid as a potential mitigating factor. While Tylenol's maker and medical experts dispute a direct causal link, citing the complexity of autism's origins, the rising autism rates and ongoing research warrant further investigation. The announcement follows HHS Secretary Kennedy's commitment to finding answers on autism's causes. Experts emphasize the multifactorial nature of autism and caution against alarmist conclusions.

Prepared by Olivia Bennett and reviewed by editorial team.